AL
MRNA icon

AJO LP’s Moderna MRNA Stock Holding History

AJO LP’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13,697
Closed -$968K – 513
2020
Q3 		$968K Buy
+13,697
New +$955K 0.01% 471

Other funds holding MRNA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

AJO LP's MRNA Position: Q4 2020 in Review

AJO LP sold out of Moderna (MRNA) in Q4 2020, closing a stake of 13,697 shares — an estimated $968K sold.

AJO LP first reported a position in MRNA in Q3 2020 and held it in 1 quarter. The position peaked at $968K in Q3 2020. 717 funds tracked by Wall St. Rank hold MRNA as of Q4 2020.

  • AJO LP reported no remaining Moderna position as of Q4 2020 after selling out during the quarter.
  • AJO LP sold 13,697 Moderna shares in Q4 2020, an estimated $968K.
  • AJO LP first reported a position in Moderna in Q3 2020 and held it in 1 quarter.
  • AJO LP's Moderna position peaked at $968K in Q3 2020.
  • 717 funds tracked by Wall St. Rank held Moderna as of Q4 2020.

Based on AJO LP's 13F filing for Q4 2020, filed 5 Feb 2021.